Warner Bros. Discovery, Inc.
Spiro compound and use thereof

Abstract:

The present disclosure relates to a series of tricyclic compounds and the use thereof as receptor agonists of sphingosine-1-phosphate subtype 1 (S1P1), and in particular relates to compounds as shown in formula (I) or pharmaceutically acceptable salts thereof. ##STR00001##